The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment

Annals of the New York Academy of Sciences

Volumn 1238, Issue 1, 2011, Pages 24-32

  Rezaei, Nima ^a,b   Mohammadinejad, Payam ^a   Aghamohammadi, Asghar ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Consanguinity; Diagnosis; Ethnicity; Iran; Primary immunodeficiency diseases; Treatment

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; AUTOIMMUNITY; AUTOSOMAL RECESSIVE DISORDER; CHRONIC GRANULOMATOUS DISEASE; COMBINED IMMUNODEFICIENCY; COMMON VARIABLE IMMUNODEFICIENCY; CONSANGUINEOUS MARRIAGE; EARLY DIAGNOSIS; ETHNIC GROUP; ETHNICITY; GENE MUTATION; GENETIC DISORDER; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INFECTION RISK; IRAN; MORBIDITY; MORTALITY; PHENOTYPE; PRIMARY IMMUNODEFICIENCY DISEASE; QUALITY OF LIFE;

EID: 82555165279     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06239.x     Document Type: Article

References (125)

1. Rezaei, N., A. Aghamohammadi & L.D. Notarangelo. 2008. Primary Immunodeficiency Diseases: Definition, Diagnosis and Management. Springer-Verlag. Berlin, Heidelberg.
2. Cooper, M.D., L.L. Lanier, M.E. Conley & J.M. Puck. 2003. Immunodeficiency disorders. Hematology Am. Soc. Hematol. Educ. Program 314-330.
3. Rezaei, N. et al. 2011. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J. Allergy Clin. Immunol. 127: 1329-1341 e2; quiz 1342-1343.
4. Rezaei, N. et al. 2011. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Br. J. Haematol. 152: 13-30.
5. Bonilla, F.A. & R.S. Geha. 2003. 12. Primary immunodeficiency diseases. J Allergy Clin. Immunol. 111: S571-S581.
6. Geha, R.S. et al. 2007. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin. Immunol. 120: 776-794.
7. Stiehm, E.R. et al. 1986. Infectious complications of the primary immunodeficiencies. Clin. Immunol. Immunopathol. 40: 69-86.
8. Hermaszewski, R.A. & A.D. Webster. 1993. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q. J. Med. 86: 31-42.
9. Plebani, A. et al. 2004. The Italian network of primary immunodeficiencies. Iran J. Allergy. Asthma Immunol. 3: 165-168.
10. Champi, C. 2002. Primary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatment. J. Pediatr. Health Care 16: 16-21.
11. Gerdes, M. et al. 2001. Taking advantage of early diagnosis: preschool children with the 22q11.2 deletion. Genet. Med. 3: 40-44.
12. Matamoros Flori, N. et al. 1997. Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults. J. Clin. Immunol. 17: 333-339.
13. Gooi, H.C. 1993. Primary immunodeficiency register, United Kingdom: update 1992. Immunodeficiency 4: 191-192.
14. Luzi, G., L. Businco & F. Aiuti. 1983. Primary immunodeficiency syndromes in Italy: a report of the national register in children and adults. J. Clin. Immunol. 3: 316-320.
15. Ryser, O., A. Morell & W.H. Hitzig. 1988. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J. Clin. Immunol. 8: 479-485.
16. Baumgart, K.W. et al. 1997. The spectrum of primary immunodeficiency disorders in Australia. J. Allergy Clin. Immunol. 100: 415-423.
17. Hayakawa, H. et al. 1981. Primary immunodeficiency syndrome in Japan. I. Overview of a nationwide survey on primary immunodeficiency syndrome. J. Clin. Immunol. 1: 31-39.
18. Boyle, J.M. & R.H. Buckley. 2007. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J. Clin. Immunol. 27: 497-502.
19. Al-Herz, W. 2008. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004-2006). J. Clin. Immunol. 28: 186-193.
20. Abuzakouk, M. & C. Feighery. 2005. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J. Clin. Immunol. 25: 73-77.
21. Iwata, C. & H. Hayakawa. 2002. Registry of cases with primary immunodeficiency syndrome in Japan. Nihon Rinsho Meneki Gakkai Kaishi 25: 289-301.
22. Leiva, L.E. et al. 2007. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J. Clin. Immunol. 27: 101-108.
23. Luzi, G., L. Businco & F. Aiuti. 1983. A national registry for primary immunodeficiency syndromes in Italy: a report for the period 1972-1982. Birth Defects Orig. Artic. Ser. 19: 161-163.
24. Fasth, A. 1982. Primary immunodeficiency disorders in Sweden: cases among children, 1974-1979. J. Clin. Immunol. 2: 86-92.
25. Affentranger, P. et al. 1993. Registry of primary immunodeficiencies in Switzerland. Immunodeficiency 4: 193-195.
26. Kirkpatrick, P. & S. Riminton. 2007. Primary immunodeficiency diseases in Australia and New Zealand. J. Clin. Immunol. 27: 517-524.
27. Mansouri, D. et al. 2005. Primary immune deficiencies presenting in adults: seven years of experience from Iran. J. Clin. Immunol. 25: 385-391.
28. Aghamohammadi, A. et al. 2002. Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults. J. Clin. Immunol. 22: 375-380.
29. Rezaei, N. et al. 2006. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J. Clin. Immunol. 26: 519-532.
30. Farhoudi, A. et al. 2005. Distribution of primary immunodeficiency disorders diagnosed in the Children's Medical Center in Iran. J. Investig. Allergol. Clin. Immunol. 15: 177-182.
31. Aghamohammadi, A. et al. 2008. ENT manifestations in Iranian patients with primary antibody deficiencies. J. Laryngol. Otol. 122: 409-413.
32. Aghamohammadi, A. et al. 2004. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia. FEMS Immunol. Med. Microbiol. 40: 113-118.
33. Rezaei, N. et al. 2006. Consanguinity in primary immunodeficiency disorders; the report from Iranian Primary Immunodeficiency Registry. Am. J. Reprod. Immunol. 56: 145-151.
34. Jalal Abbasi-Shavazi, M., P. McDonald & M. Hosseini-Chavoshi. 2008. Modernization or cultural maintenance: the practice of consanguineous marriage in Iran. J. Biosoc. Sci. 40: 911-933.
35. Saadat, M., M. Ansari-Lari & D.D. Farhud. 2004. Consanguineous marriage in Iran. Ann. Hum. Biol. 31: 263-269.
36. Aghamohammadi, A. et al. 2010. Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults. J. Investig. Allergol. Clin. Immunol. 20: 372-379.
37. Al-Attas, R.A. & A.H. Rahi. 1998. Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia. J. Clin. Immunol. 18: 368-371.
38. Zelazko, M. et al. 1998. Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases. J. Clin. Immunol. 18: 161-166.
39. Lim, D.L. et al. 2003. Primary immunodeficiency diseases in Singapore-the last 11 years. Singapore Med. J. 44: 579-586.
40. Al-Herz, W. et al. 2008. Primary immunodeficiency disorders: survey of pediatricians in Kuwait. J. Clin. Immunol. 28: 379-383.
41. Lee, W.I. et al. 2005. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J. Clin. Immunol. 25: 162-173.
42. Grumach, A.S. et al. 1997. Brazilian report on primary immunodeficiencies in children: 166 cases studied over a follow-up time of 15 years. J. Clin. Immunol. 17: 340-345.
43. Leiva, L.E. et al. 2011. Primary immunodeficiency diseases in Latin America: proceedings of the Second Latin American Society for Immunodeficiencies (LASID) Advisory Board. Allergol. Immunopathol. (Madr.) 39: 106-110.
44. Movahedi, M. et al. 2004. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. Int. Arch. Allergy Immunol. 134: 253-259.
45. Yeganeh, M. et al. 2008. Severe combined immunodeficiency: a cohort of 40 patients. Pediatr. Allergy Immunol. 19: 303-306.
46. Aghamohammadi, A. et al. 2005. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin. Diagn. Lab. Immunol. 12: 825-832.
47. Moin, M. et al. 2007. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr. Neurol. 37: 21-28.
48. Aghamohammadi, A. et al. 2006. Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia. Int. Arch. Allergy Immunol. 141: 408-414.
49. Moin, M. et al. 2004. X-linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol. Invest. 33: 81-93.
50. Aghamohammadi, A. et al. 2009. IgA deficiency: correlation between clinical and immunological phenotypes. J. Clin. Immunol. 29: 130-136.
51. Sadeghi-Shabestari, M. & N. Rezaei. 2009. Disseminated bacille Calmette-Guerin in Iranian children with severe combined immunodeficiency. Int. J. Infect. Dis. 13: 420-423.
52. Rezaei, N. et al. 2011. Tuberculosis: a new look at an old disease. Expert Rev. Clin. Immunol. 7: 129-131.
53. Elder, M.E. 2000. T-cell immunodeficiencies. Pediatr. Clin. North Am. 47: 1253-1274.
54. Bittles, A. 2001. Consanguinity and its relevance to clinical genetics. Clin. Genet. 60: 89-98.
55. Jaber, L., G.J. Halpern & M. Shohat. 1998. The impact of consanguinity worldwide. Community Genet. 1: 12-17.
56. Hasui, M. 1999. Chronic granulomatous disease in Japan: incidence and natural history. The Study Group of Phagocyte Disorders of Japan. Pediatr. Int. 41: 589-593.
57. Winkelstein, J.A. et al. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79: 155-169.
58. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies 1999. Clin. Exp. Immunol. 118(Suppl 1): 1-28.
59. Fischer, A. et al. 2005. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol. Rev. 203: 98-109.
60. Cunningham-Rundles, C. & C. Bodian. 1999. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 92: 34-48.
61. Rezaei, N. et al. 2008. T-helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. J. Investig. Allergol. Clin. Immunol. 18: 449-453.
62. Rezaei, N. et al. 2009. Association of IL-4 and IL-10 gene promoter polymorphisms with common variable immunodeficiency. Immunobiology. 215: 81-87.
63. Rezaei, N., A. Aghamohammadi & R.C. Read. 2008. Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease. Iran J. Allergy Asthma Immunol. 7: 231-234.
64. Rezaei, N. et al. 2009. Cytokine gene polymorphisms in common variable immunodeficiency. Int. Arch. Allergy Immunol. 150: 1-7.
65. Rezaei, N. et al. 2008. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency. Clin. Vaccine Immunol. 15: 607-611.
66. Rezaei, N. et al. 2007. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine 25: 5308-5314.
67. Rezaei, N. et al. 2009. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin. Exp. Immunol. 155: 21-27.
68. Mohammadi, J. et al. 2009. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J. Clin. Immunol. 29: 777-785.
69. Aghamohammadi, A. et al. 2008. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology 213: 447-454.
70. Rezaei, N. et al. 2008. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications. J. Clin. Immunol. 28: 78-84.
71. Shabestari, M.S. et al. 2007. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J. Clin. Immunol. 27: 510-516.
72. Abedi, M. et al. 2000. Report from the ESID Registry of Primary Immunodeficiencies. Available at: (Accessed July 2000).
73. Ersoy, F. & A.I. Berkel. 1974. Clinical and immunological studies in twenty families with ataxia-telangiectasia. Turk. J. Pediatr. 16: 145-160.
74. Donbak, L. 2004. Consanguinity in Kahramanmaras city, Turkey, and its medical impact. Saudi Med. J. 25: 1991-1994.
75. Notarangelo, L.D. et al. 2009. Primary immunodeficiencies: 2009 update. J. Allergy Clin. Immunol. 124: 1161-1178.
76. Woroniecka, M. & M. Ballow. 2000. Office evaluation of children with recurrent infection. Pediatr. Clin. North Am. 47: 1211-1224.
77. Aghamohammadi, A., M. Moin & N. Rezaei. 2010. History of primary immunodeficiency diseases in Iran. Iran J. Pediatr. 20: 16-34.
78. Cunningham-Rundles, C. 1989. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J. Clin. Immunol. 9: 22-33.
79. Hammarstrom, L., I. Vorechovsky & D. Webster. 2000. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin. Exp. Immunol. 120: 225-231.
80. Aghamohammadi, A. et al. 2006. Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk. Lymphoma 47: 343-346.
81. Aghamohammadi, A. et al. 2007. Mortality and morbidity in common variable immunodeficiency. J. Trop. Pediatr. 53: 32-38.
82. Rezaei, N. et al. 2010. Cytokine production by activated T cells in common variable immunodeficiency. J. Investig. Allergol. Clin. Immunol. 20: 244-251.
83. Rezaei, N. et al. 2010. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency. Clin. Vaccine Immunol. 17: 524-528.
84. Rezaei, N. et al. 2010. B-cell-T-cell activation and interaction in common variable immunodeficiency. Hum. Immunol. 71: 355-362.
85. Aghamohammadi, A., N. Parvaneh & N. Rezaei. 2009. Common variable immunodeficiency: a heterogeneous group needs further subclassification. Expert Rev. Clin. Immunol. 5: 629-631.
86. Urschel, S. et al. 2009. Common variable immunodeficiency disorders in children: delayed diagnosis despite typical clinical presentation. J. Pediatr. 154: 888-894.
87. Rezaei, N. et al. 2007. The clinical, immunohematological, and molecular study of Iranian patients with severe congenital neutropenia. J. Clin. Immunol. 27: 525-533.
88. Rezaei, N. et al. 2008. Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia. Int. Arch. Allergy Immunol. 147: 255-259.
89. Rezaei, N. et al. 2007. Association of HAX1 deficiency with neurological disorder. Neuropediatrics 38: 261-263.
90. Salipante, S.J. et al. 2007. Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia. Hum. Mutat. 28: 874-881.
91. Aghamohammadi, A. et al. 2008. Progression of selective IgA deficiency to common variable immunodeficiency. Int. Arch. Allergy Immunol. 147: 87-92.
92. Rezaei, N. 2006. TNF-receptor-associated periodic syndrome (TRAPS): an autosomal dominant multisystem disorder. Clin. Rheumatol. 25: 773-777.
93. Klein, C. et al. 2007. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat. Genet. 39: 86-92.
94. Boztug, K. et al. 2009. A syndrome with congenital neutropenia and mutations in G6PC3. N. Engl. J. Med. 360: 32-43.
95. Glocker, E.O. et al. 2009. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361: 1727-1735.
96. Yeganeh, M. et al. 2008. Toll-like receptor stimulation induces higher TNF-alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndrome. Int. Arch. Allergy Immunol. 146: 190-194.
97. Germeshausen, M. et al. 2008. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood 111: 4954-4957.
98. Engelhardt, K.R. et al. 2009. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol. 124: 1289-1302 e4.
99. Vogt, G. et al. 2005. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat. Genet. 37: 692-700.
100. Fahimzad, A. et al. 2008. Necrosis of nasal cartilage due to mucormycosis in a patient with severe congenital neutropenia due to HAX1 deficiency. J. Investig. Allergol. Clin. Immunol. 18: 469-472.
101. Mamishi, S. et al. 2009. Severe congenital neutropenia in 2 siblings of consanguineous parents. The role of HAX1 deficiency. J. Investig. Allergol. Clin. Immunol. 19: 500-503.
102. Carlsson, G. et al. 2008. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J. Intern. Med. 264: 388-400.
103. Matsubara, K. et al. 2007. Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency. Haematologica 92: e123-e125.
104. Ishikawa, N. et al. 2008. Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J. Med. Genet. 45: 802-807.
105. de Beaucoudrey, L. et al. 2010. Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 89: 381-402.
106. Boisson-Dupuis, S., J. El Baghdadi, N. Parvaneh, et al. 2011. IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One 6: e18524.
107. Tabarsi, P. et al. 2011. Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency. J. Clin. Immunol. 31: 537-539.
108. Mansouri, D. et al. 2005. Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. Eur. J. Pediatr. 164: 753-757.
109. Engelhardt, K.R. et al. 2009. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol. 124: 1289-1302 e4.
110. Woellner, C. et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J. Allergy Clin. Immunol. 125: 424-432 e8.
111. Rezaei, N. & A. Aghamohammadi. 2011. Hyper-IgE syndrome. J. Postgrad. Med. 56: 63-64.
112. Aghamohammadi, A. et al. 2009. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J. Clin. Immunol. 29: 769-776.
113. Safari, M. et al. 2008. Onychomadesis in a patient with immunoglobulin class switch recombination deficiency. Iran J. Allergy Asthma Immunol. 7: 41-44.
114. Kashef, S. et al. 2009. Isolated growth hormone deficiency in a patient with immunoglobulin class switch recombination deficiency. J. Investig. Allergol. Clin. Immunol. 19: 233-236.
115. Aghamohammadi, A. et al. 2011. Impact of delayed diagnosis in children with primary antibody deficiencies. J. Microbiol. Immunol. Infect. 44: 229-234.
116. Aghamohammadi, A. et al. 2011. Health-related quality of life in primary antibody deficiency. Iran J. Allergy Asthma Immunol. 10: 47-51.
117. Shami, S.A., J.C. Grant & A.H. Bittles. 1994. Consanguineous marriage within social/occupational class boundaries in Pakistan. J. Biosoc. Sci. 26: 91-96.
118. Bener, A. et al. 1996. Consanguinity and associated socio-demographic factors in the United Arab Emirates. Hum. Hered. 46: 256-264.
119. Jurdi, R. & P.C. Saxena. 2003. The prevalence and correlates of consanguineous marriages in Yemen: similarities and contrasts with other Arab countries. J. Biosoc. Sci. 35: 1-13.
120. Khlat, M. 1988. Consanguineous marriages in Beirut: time trends, spatial distribution. Soc. Biol. 35: 324-330.
121. Hafez, M. et al. 1983. Consanguineous matings in the Egyptian population. J. Med. Genet. 20: 58-60.
122. Pourpak, Z. et al. 2006. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J. Microbiol. Immunol. Infect. 39: 114-120.
123. Atarod, L. et al. 2007. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy. Iran J. Allergy Asthma Immunol. 6: 37-40.
124. Aghamohammadi, A. et al. 2004. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Ann. Allergy Asthma Immunol. 92: 60-64.
125. Dashti-Khavidaki, S. et al. 2009. Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. J. Investig. Allergol. Clin. Immunol. 19: 139-145.